top of page
PIPELINE
We are advancing a robust pipeline of Supercharged Cell therapies powered by our proprietary cell enhancements
Product
Cell Type
Target / Indications
Discovery
Lead Optimization
IND
CIB-F1-T
T cell autologous
Cellinfinity's novel target & novel enhancements for solid tumors
CIB-F1-N
NK cell allogeneic
Cellinfinity's novel target & novel enhancements for solid tumors
Cellinfinity has multiple pre-clinical candidates available for collaborations.
bottom of page